Fulgent Genetics (FLGT) Other Non-Current Assets (2015 - 2026)

Fulgent Genetics has disclosed Other Non-Current Assets across 12 years of filings, most recently posting $23.9 million for Q2 2026.

• In Q2 2026, Other Non-Current Assets rose 2.78% year-over-year to $23.9 million; the TTM figure through Jun 2026 stood at $23.9 million (up 2.78% YoY), while the FY2025 annual figure was $22.9 million, down 31.69% from the prior year.
• Other Non-Current Assets came in at $23.9 million for Q2 2026 at Fulgent Genetics, down from $25.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $61.8 million in Q2 2022 to a low of $22.9 million in Q4 2025.
• Average Other Non-Current Assets over 5 years is $36.5 million, with a median of $34.1 million recorded in 2022.
• Year-over-year, Other Non-Current Assets soared 594.36% in 2022 and tumbled 40.5% in 2025.
• Over 5 years, Other Non-Current Assets stood at $44.1 million in 2022, then slipped by 20.9% to $34.9 million in 2023, then declined by 4.13% to $33.5 million in 2024, then sank by 31.69% to $22.9 million in 2025, then climbed by 4.78% to $23.9 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $23.9 million in Q2 2026, $25.0 million in Q1 2026, and $22.9 million in Q4 2025.